Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden · Delayed Price · Currency is SEK 0.1090
-0.0035 (-3.11%)
Sep 4, 2026, 10:32 AM CET
Spago Nanomedical AB Market Cap
Spago Nanomedical AB has a market cap or net worth of 89.82 million as of September 3, 2026. Its market cap has decreased by -8.20% in one year.
Market Cap
89.82M
Enterprise Value
57.31M
Revenue
3.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
ChartMarket Cap Chart
Since January 16, 2013, Spago Nanomedical AB's market cap has increased from 46.44M to 89.82M, an increase of 93.40%. That is a compound annual growth rate of 4.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 89.82M | 16.54% |
| Dec 30, 2025 | 77.07M | 12.93% |
| Dec 30, 2024 | 68.25M | -4.38% |
| Dec 29, 2023 | 71.37M | 24.57% |
| Dec 30, 2022 | 57.29M | -71.02% |
| Dec 30, 2021 | 197.67M | -26.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 136.50M |
| Active Biotech AB | 134.97M |
| Simris Group AB (PUBL) | 132.28M |
| Biovica International AB | 131.36M |
| Nanologica AB | 123.95M |
| Annexin Pharmaceuticals AB | 93.89M |
| Ascelia Pharma AB | 82.12M |
| OncoZenge AB | 65.53M |